Zhibiao Wang Selected Research

High-Intensity Focused Ultrasound Ablation

1/2022	Dosimetric analysis of ultrasound-guided high intensity focused ultrasound ablation for breast fibroadenomas: a retrospective study.
1/2021	Ultrasound-guided high intensity focused ultrasound ablation for uterine fibroids: long-term outcomes and factors affecting local recurrence.
1/2019	Reasons for different therapeutic effects of high-intensity focused ultrasound ablation on excised uterine fibroids with different signal intensities on T2-weighted MRI: a study of histopathological characteristics.
6/2016	Folate-targeted perfluorohexane nanoparticles carrying bismuth sulfide for use in US/CT dual-mode imaging and synergistic high-intensity focused ultrasound ablation of cervical cancer.
4/2015	Intraprocedure contrast enhanced ultrasound: the value in assessing the effect of ultrasound-guided high intensity focused ultrasound ablation for uterine fibroids.
4/2015	Factors influencing the dosimetry for high-intensity focused ultrasound ablation of uterine fibroids: a retrospective study.
1/2015	Efficacy of high-intensity focused ultrasound ablation for adenomyosis therapy and sexual life quality.
5/2014	Potential enhancement of intravenous nano-hydroxyapatite in high-intensity focused ultrasound ablation for treating hepatocellular carcinoma in a rabbit model.
11/2012	Feasibility of MRI-guided high intensity focused ultrasound treatment for adenomyosis.
9/2010	High-intensity focused ultrasound ablation: effective and safe therapy for solid tumors in difficult locations.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhibiao Wang Research Topics

Disease

24	Neoplasms (Cancer) 01/2022 - 11/2002
10	Leiomyoma (Uterine Fibroids) 01/2021 - 12/2012
6	Necrosis 06/2016 - 04/2003
5	Neoplasm Metastasis (Metastasis) 06/2022 - 05/2002
4	Breast Neoplasms (Breast Cancer) 01/2018 - 09/2010
4	Hepatocellular Carcinoma (Hepatoma) 02/2016 - 02/2009
3	Adenomyosis 06/2022 - 11/2012
2	Osteosarcoma (Osteogenic Sarcoma) 07/2021 - 06/2010
2	Uterine Cervicitis (Cervicitis) 01/2021 - 05/2015
2	Melanoma (Melanoma, Malignant) 01/2020 - 02/2015
2	Residual Neoplasm 01/2015 - 06/2014
2	Thrombosis (Thrombus) 09/2010 - 02/2010
2	Ovarian Neoplasms (Ovarian Cancer) 07/2004 - 04/2004
2	Carcinoma (Carcinomatosis) 04/2004 - 01/2003
1	Endometriosis 06/2022
1	Fibroadenoma 01/2022
1	Cicatrix (Scar) 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Papillomavirus Infections 01/2021
1	Uterine Cervical Dysplasia 01/2021
1	Human Influenza (Influenza) 08/2018
1	Glioma (Gliomas) 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2017
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2016
1	Teratoma (Teratoid Tumor) 01/2016
1	Hypertension (High Blood Pressure) 10/2015
1	Vulvar Diseases 05/2015

Drug/Important Bio-Agent (IBA)

8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2003
5	Contrast MediaIBA 06/2016 - 12/2012
4	Biological ProductsIBA 12/2015 - 05/2003
3	Therapeutic UsesIBA 01/2021 - 01/2018
3	perflexane (perfluorohexane)FDA Link 06/2016 - 08/2013
3	ferric oxide (iron oxide)IBA 06/2015 - 08/2012
3	Capsules (Microcapsules)IBA 06/2015 - 08/2012
2	Proteins (Proteins, Gene)FDA Link 06/2022 - 12/2015
2	Biomarkers (Surrogate Marker)IBA 06/2022 - 07/2021
2	beta-lapachoneIBA 06/2021 - 01/2020
2	pullulanIBA 01/2020 - 06/2019
2	Drug CarriersIBA 06/2019 - 06/2014
2	NanodiamondsIBA 06/2019 - 01/2018
2	Estrogen ReceptorsIBA 12/2015 - 09/2010
2	salicylhydroxamic acid (SHAM)IBA 02/2015 - 01/2015
2	contrast agent BR1IBA 10/2014 - 12/2012
2	Polylactic Acid-Polyglycolic Acid CopolymerIBA 06/2014 - 08/2012
2	Verapamil (Calan)FDA LinkGeneric 07/2004 - 01/2003
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2022
1	Long Noncoding RNAIBA 07/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2021
1	Glutathione (Reduced Glutathione)IBA 06/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2021
1	InterferonsIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Granzymes (Granzyme)IBA 01/2021
1	A-factor (Streptomyces)IBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Nanoparticle Drug Delivery SystemIBA 01/2020
1	MetalloproteinsIBA 01/2020
1	ProdrugsIBA 01/2020
1	Tissue Inhibitor of Metalloproteinase-3IBA 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	Retinaldehyde (Retinal)IBA 06/2019
1	VaccinesIBA 08/2018
1	Nasal SpraysIBA 08/2018
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2018
1	Liposomes (Liposome)IBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2018
1	AntigensIBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	poly(lactide) (polylactic acid)IBA 01/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2017
1	glycolic acid (glycolate)IBA 01/2017
1	Folic Acid (Vitamin M)FDA LinkGeneric 06/2016
1	bismuth sulfideIBA 06/2016
1	NanocapsulesIBA 02/2016
1	Ethiodized Oil (Ethiodol)FDA Link 02/2016
1	Bone Morphogenetic Protein 4IBA 01/2016
1	Protein Isoforms (Isoforms)IBA 12/2015
1	Estrogens (Estrogen)FDA Link 12/2015
1	Messenger RNA (mRNA)IBA 12/2015
1	Biocompatible Materials (Biomaterials)IBA 06/2015
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 01/2015

Therapy/Procedure

19	Therapeutics 01/2022 - 04/2004
11	High-Intensity Focused Ultrasound Ablation 01/2022 - 06/2010
6	Drug Therapy (Chemotherapy) 06/2021 - 05/2002
6	Microbubbles 01/2021 - 02/2010
3	Extracorporeal Shockwave Therapy 01/2020 - 05/2002
3	Ultrasonic Therapy 05/2015 - 11/2004
2	Aftercare (After-Treatment) 12/2015 - 12/2003
2	Denervation 10/2015 - 05/2013
2	Lasers (Laser) 02/2009 - 11/2008
1	Immunotherapy 01/2021
1	Precision Medicine 01/2017
1	Duration of Therapy 02/2016
1	Hysterectomy 12/2015
1	Ablation Techniques 01/2015
1	Intralesional Injections 01/2015
1	Injections 01/2015